We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




First Wearable Platform Allows Physicians to Offer Patients Full Routine Cardiopulmonary Examinations

By HospiMedica International staff writers
Posted on 09 Jan 2024
Print article
Image: The SimpleSense non-invasive undergarment monitors multiple patient vitals (Photo courtesy of Nanowear)
Image: The SimpleSense non-invasive undergarment monitors multiple patient vitals (Photo courtesy of Nanowear)

Until now, the healthcare wearables and software platforms available have been limited in their scope and duration, or they have been unreliable and unverified for diagnosing conditions under real-world conditions. Now, a groundbreaking wearable platform employing patented nanosensors and sophisticated AI can empower physicians to conduct comprehensive routine cardiopulmonary examinations for patients at home, in healthcare facilities, and during clinical research.

Nanowear’s (New York, NY, USA; www.nanowearinc.com) SimpleSense is an AI-driven digital platform paired with a wearable device that captures and analyzes over 85 unique biomarker data points from the heart, lungs, hemodynamics, and central vascular system. This platform delivers high-quality, continuous, and synchronized biometric data, compiling cardiopulmonary assessments millisecond by millisecond to aid medical professionals in managing patients remotely. Leveraging proprietary nanosensors and sophisticated algorithms, SimpleSense is the world’s first comprehensive wearable platform, effectively supplanting primary diagnostic tools like the blood pressure cuff, digital stethoscope, multi-channel ECG, hemodynamic monitor, pulse oximeter, spirometer, and actigraphy monitors.

SimpleSense has obtained FDA 510(k) clearance as a novel AI-driven Software-as-a-Medical Device (SaMD). With its fourth FDA 510(k) clearance, alongside 13 granted and 12 pending patents that cover its nanotechnology, scalable nanosensor manufacturing, multi-parametric wearable, software platform, data ingestion pipeline, and AI algorithms in a fully integrated ecosystem, Nanowear’s SimpleSense is uniquely positioned in the market. It is indicated for use in various settings, from at-home and healthcare facilities to clinical research. The innovative 4-decision tree algorithmic model, SimpleSense-BP, underwent testing across three study arms with both training and validation conducted in diverse geographies and demographic populations, reflecting the most recent US census and providing a broad application to the entire hypertensive population. SimpleSense-BP is validated to monitor changes of > +/- 15mmHg systolic and +/- 10mmHg diastolic blood pressures over a continuous recording period for all classes of hypertension, using its wearable undergarment and AI platform.

“This FDA clearance represents an exciting and differentiating moment for Nanowear. Accelerated by the pandemic, the market has been eagerly searching for reliable, clinical-grade wearable, and data service solutions that find product market fit with the following three attributes: at-home, utilizing AI, and a proven team that executes,” said Venk Varadan, CEO and co-founder of Nanowear, emphasizing the company’s distinction as the world’s only nanotechnology-based embedded sensor platform fueling irreproducible AI algorithms. “This SaMD is just the first example of what our nanotechnology and AI is capable of, in understanding the individualized risk signatures and cardiopulmonary care pathways of each patient, materially enabling precision medicine.”

Related Links:
Nanowear

Gold Member
12-Channel ECG
CM1200B
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Diagnostic Display System
C3MPL

Print article
Detecto

Channels

Surgical Techniques

view channel
Image: ROSA Shoulder is a groundbreaking robotic system for anatomic and reverse shoulder arthroplasty (Photo courtesy of Zimmer Biomet)

World's First Robotic Assistant for Shoulder Replacement Surgery Helps Perform Highly Complex Procedures

A key challenge in performing a shoulder replacement is accurate glenoid and humeral placement, which is a critical factor for post-operative function and long-term implant survival. Now, a groundbreaking... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The new eye-safe laser technology can diagnose traumatic brain injury (Photo courtesy of 123RF)

Novel Diagnostic Hand-Held Device Detects Known Biomarkers for Traumatic Brain Injury

The growing need for prompt and efficient diagnosis of traumatic brain injury (TBI), a major cause of mortality globally, has spurred the development of innovative diagnostic technologies.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.